Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03277105 |
|---|---|
| Brief Title: | A Study of Subcutaneous Versus (vs.) Intravenous Administration of Daratumumab in Participants With Relapsed or Refractory Multiple Myeloma |
| First Submitted : | September 7, 2017 |
| First Submitted that Met QC Criteria : | September 7, 2017 |
| First Posted : | September 8, 2017 |
| Results First Submitted : | June 19, 2020 |
| Results First Posted with QC Comments : | July 8, 2020 |
| Results First Submitted that Met QC Criteria : | July 24, 2020 |
| Results First Posted : | July 27, 2020 |
| Last Update Submitted that Met QC Criteria : | March 11, 2024 |
| Last Update Posted : | March 13, 2024 |